NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT00101205 2014-02-24Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Terminated40 enrolled
NCT00470405 2011-04-18Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or LymphomaVanderbilt-Ingram Cancer CenterPhase 1 Completed25 enrolled